Clinical and pharmaceutical success from discovery to regulatory approval: biomarkers, modeling and analytical technologies. (October 2017)

• Record Type: Journal Article
• Authors: Zhang, Tianyi (Tee); Weng, Naidong; Lee, Mike
• Is Part Of: Bioanalysis. Volume 9:Number 19(2017)
• Page Start: 1437
• Page End: 1440
• Publication Date: 2017-10
• Subjects: biomarker -- biomolecule -- DMPK -- drug development -- generic drug -- LC–MS bioanalysis -- quality and efficacy evaluation; Drugs -- Analysis -- Periodicals; 615.19005
• DOI: 10.4155/bio-2017-4978
• Languages: English
• ISSNs: 1757-6180

Abstract

The 8th Annual Shanghai Symposium on Clinical and Pharmaceutical Solutions through Analysis (CPSA): Clinical and Pharmaceutical Success from Discovery to Regulatory Approval: Biomarkers, Modeling and Analytical Technologies (CPSA Shanghai 2017); Renaissance Shanghai Pudong Hotel, Shanghai, China, 12–14 April 2017 was held on 12–14 April 2017 in Shanghai, China. The meeting was featured with highly interactive events including diversified symposia, workshops, roundtable discussions, conference awards and poster sessions. There were over 220 participants with 61 oral presentations and 20 posters presented. In addition, the meeting included a preconference workshop with an inaugural session on the evaluation of quality and efficacy for generic drugs in China.